Gurlek, A. Et Al. 2001. Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure. JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.5 , 279-282.

Gurlek, A., Kilickap, M., DİNÇER, İ., Dandachi, R., Tutkak, H., & Oral, D., (2001). Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure. JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.5, 279-282.

Gurlek, A Et Al. "Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure," JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.5, 279-282, 2001

Gurlek, A Et Al. "Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure." JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.5, pp.279-282, 2001

Gurlek, A. Et Al. (2001) . "Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure." JOURNAL OF CARDIOVASCULAR RISK , vol.8, no.5, pp.279-282.

@article{article, author={A Gurlek Et Al. }, title={Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure}, journal={JOURNAL OF CARDIOVASCULAR RISK}, year=2001, pages={279-282} }